Literature DB >> 16887737

Travelling to Africa: health risks reviewed.

Stephen Toovey1.   

Abstract

Africa's varied ecology presents a wide range of travel health threats: infections; accidents; envenomations; an uncertain drug supply; problematic access to competent medical care outside South Africa. Important vaccine preventable diseases include yellow fever, meningococcal disease, typhoid, polio, rabies, and hepatitis A and B; routine vaccinations should be up to date. Much, but not all, of sub-Saharan Africa is malarious with chloroquine resistant falciparum dominating; chemoprophylaxis and personal protection measures will often be indicated. Other threats are less obvious, e.g. helminth and protozoal infections. The immunocompromised and other high-risk groups may require special attention. Risk mitigation strategies may include education, vaccination, chemoprophylaxis, personal protection measures, provision of treatment and equipment packs, behaviour modification, and evacuation insurance.

Entities:  

Mesh:

Year:  2005        PMID: 16887737     DOI: 10.1016/j.tmaid.2005.06.011

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  3 in total

1.  Multicentric evaluation of new commercial enzyme immunoassays for the detection of immunoglobulin M and total antibodies against hepatitis A virus.

Authors:  M C Arcangeletti; E Dussaix; F Ferraglia; A M Roque-Afonso; A Graube; C Chezzi
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

2.  Assessment of yellow fever epidemic risk: an original multi-criteria modeling approach.

Authors:  Sylvie Briand; Ariel Beresniak; Tim Nguyen; Tajoua Yonli; Gerard Duru; Chantal Kambire; William Perea
Journal:  PLoS Negl Trop Dis       Date:  2009-07-14

3.  Determinants of Compliance of Travelers with Vaccination and Malaria Prophylaxis at a Travel Clinic.

Authors:  Hea Yoon Kwon; HyeJin Lee; Jae Hyoung Im; Shin Goo Park; Yeon Ji Lee; Ji Hyeon Baek; Jin Soo Lee
Journal:  J Korean Med Sci       Date:  2019-08-26       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.